What Risk Does the Coronavirus Pose for Cannabis Companies?

Eight Capital analyst Graeme Kreindler has shared points of concern for the Canadian cannabis industry amid the increased COVID-19 tension.

In a note issued earlier this week, a cannabis analyst offered a look at issues investors should be aware of when it comes to the spread of the novel coronavirus in Canada.

Graeme Kreindler, equity research analyst with boutique financial institution Eight Capital, indicated that the highest areas of concern across the supply chain in cannabis are lighting in the cultivation sector and vape hardware as part of manufacturing.

As safety measures are put in place for the prevention of COVID-19, the disease caused by this coronavirus, the analyst also highlighted machinery and environmental control segments attached to cannabis operations as areas to monitor.

He said that concerns over lighting equipment and vape hardware are due to connections with manufacturing in Asia, primarily China.

“This comes at a time where vape sales are expected to ramp up given their recent launch in the Canadian adult-use market and a rebound in sales in the US, after concerns late last year on vape-related illness,” Kreindler said in his note, according to a report from BNN Bloomberg.

Vape sales have become increasingly significant for companies given the recent second stage of legalization in Canada.

“Virtually all vape hardware manufactured in China per our discussions with operators. Build-up of inventory post-vape crisis could mitigate some risk. Tight capital conditions not conductive to every operator being able to build up and sustain large inventory positions,” the analyst wrote.

Kreindler covers an array of Canadian cannabis names like Tilray (NASDAQ:TLRY), Aurora Cannabis (NYSE:ACB,TSX:ACB) and Canopy Growth (NYSE:CGC,TSX:WEED), alongside US firms such as Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) and Harvest Health and Recreation (CSE:HARV,OTCQX:HRVSF).

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.

Featured
WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. resulting from allegations that Cronos may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs ...

WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

read more Show less
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofCronos Group, Inc. . Investors who purchased Cronos sharesare encouraged to obtain additional information and assist the investigation by visiting the firm's site: investigation concerns whether Cronos and certain of its officers andor directors have violated federal securities laws.On November 9, 2021, Cronos filed a Form ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofCronos Group, Inc. ("Cronos" or the "Company") (NASDAQ:CRON). Investors who purchased Cronos sharesare encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.comcron

The investigation concerns whether Cronos and certain of its officers and/or directors have violated federal securities laws.

read more Show less
Goodness Growth Holdings, Inc. a physician-led, science-focused cannabis company and IP developer, today announced the launch of HiColor™ gummies and availability in Maryland through the Company's wholesale and retail channels. The new line of cannabis infused edibles will be available in three formulations and five gourmet flavors. "HiColor Gummies are an exciting addition to our growing portfolio of brands that ...

- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the launch of HiColor™ gummies and availability in Maryland through the Company's wholesale and retail channels. The new line of cannabis infused edibles will be available in three formulations and five gourmet flavors.

read more Show less

MARKETS

Markets
TSX21162.65+301.55
TSXV920.55+22.85
DOW35719.43+492.40
S&P 5004686.75+95.08
NASD15686.92+461.76
ASX7313.90+68.80

COMMODITIES

Commodities
Gold1784.41-0.20
Silver22.42-0.09
Copper4.340.00
Palladium1846.00+2.03
Platinum959.38+3.38
Oil72.28+0.23
Heating Oil2.25+0.03
Natural Gas3.85+0.14